Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More

Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More

Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More

Singapore Clinical Trial: A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3537031 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3537031 in Healthy Participants

Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability ... Read More

Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab... Read More

Singapore Clinical Trial: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared with Investigator’s Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)

Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety o... Read More

Kursi donates N100m empowerment fund, healthcare support to Eji-Dongari community

Nigeria, July 29 -- Kursi Investments Limited has donated a N100 million empowerment fund and healthcare support to beneficiaries in the Eji-Dongari host community in Kwara State as part of its Corpor... Read More

Alia Bhatt urges support for Assam flood victims, calls for immediate relief efforts

India, July 29 -- Actor Alia Bhatt has appealed to her followers to support relief efforts for flood-affected communities in Assam, highlighting the recurring devastation caused by annual floods and u... Read More

స్పెషలిస్ట్ డాక్టర్ పోస్టుల ఫలితాలు విడుదల.. ఈ లింక్ క్లిక్ చేసి రిజల్ట్ చూసుకోండి

భారతదేశం, జూలై 29 -- డైరెక్టరేట్ ఆఫ్ సెకండరీ హెల్త్ కేర్ (తెలంగాణ వైద్య విధాన పరిషత్) పరిధిలోని ప్రభుత్వ హాస్పిటళ్లలో స్పెషలిస్ట్ డాక్టర్ పోస్టుల ఫలితాలు విడుదల అయ్యాయి. జనరల్ సర్జరీ, జనరల్ మెడిసిన్, ... Read More

Vishal Dadlani backs Gen Z protesters, rebukes criticism over protest language

India, July 29 -- Singer-composer Vishal Dadlani has defended Gen Z protesters amid criticism from actor-politician Kangana Ranaut, arguing that the focus should be on the treatment of students during... Read More

• ««
• «
• 1157
• 1158
• 1159
• 1160
• 1161
• 1162
• 1163
• 1164
• 1165
• 1166
• »
• »»